In this Healio Video Perspective, Dante J. Pieramici, MD, discusses a trial investigating contrast sensitivity as a visual ...

Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...

Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc., in collaboration with Asher ...

NEW YORK – Krystal Biotech has discontinued a Phase I/II clinical trial evaluating an injected version of its gene therapy KB707 in locally advanced or metastatic solid tumors, including melanoma.

Offering a modest gift card significantly increased enrollment of low-income individuals in a patient registry designed to ...

ALEX TORDOFF is relishing the prospect of fulfilling a lifelong dream as he saddles up for his Defender Burghley Horse Trials debut.

Vascular toxicity associated with cancer therapies is a leading cause of cardiovascular adverse events in patients with ...

NCX 470 0.1%, a novel nitric oxide-donating bimatoprost eye drop, achieved its primary endpoint in the phase 3 Denali ...